Bristol-Myers Squibb Company (BMY)

Featured here, the Balance Sheet for Bristol-Myers Squibb Company, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

67.70 +0.73 (+1.08%)

20:52:46 Real-time Cboe USD Disclaimer

BMY Balance Sheet

Total Current Assets

Name	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Current Assets	27,273	26,796	30,186	30,121	33,262
Cash and Short Term Investments	9,027	13,266	15,196	17,221	-
Cash	-	-	-	-	-
Cash & Equivalents	9,123	7,734	10,750	12,369	13,979
Short Term Investments	1,293	2,516	2,827	2,987	-
Total Receivables, Net	13,240	12,540	11,103	9,369	-
Accounts Receivables - Trade, Net	10,059	9,473	8,921	7,979	-
Total Inventory	2,074	2,142	2,104	2,095	-
Prepaid Expenses	2,786	-	-	-	-
Other Current Assets, Total	1,744	2,455	2,238	1,718	1,430
Total Assets	98,196	100,357	103,034	109,314	-
Property/Plant/Equipment, Total - Net	7,475	6,918	6,810	6,941	6,968
Property/Plant/Equipment, Total - Gross	11,057	10,835	11,109	11,001	-
Accumulated Depreciation, Total	-4,139	-4,025	-4,168	-4,033	-
Goodwill, Net	21,112	20,446	20,500	20,502	-
Intangibles, Net	35,859	38,179	37,690	40,103	42,527
Long Term Investments	1,959	1,973	2,185	2,713	-
Note Receivable - Long Term	3,181	3,067	2,182	-	-
Other Long Term Assets, Total	1,356	1,343	1,447	3,342	-
Other Assets, Total	-7,884	-5,542	-3,735	-2,717	-4,062
Total Current Liabilities	21,890	18,930	20,915	22,821	21,868
Accounts Payable	3,040	2,595	2,882	2,944	2,949
Payable/Accrued	-	-	-	-	-
Accrued Expenses	10,238	9,839	8,761	8,148	10,104
Notes Payable/Short Term Debt	229	307	225	184	-
Current Port. of LT Debt/Capital Leases	2,070	4,813	7,468	4,933	-
Other Current liabilities, Total	4,212	4,197	4,152	4,036	3,867
Total Liabilities	65,702	65,462	67,696	71,389	73,308
Total Long Term Debt	37,028	37,116	37,450	39,605	-
Long Term Debt	37,028	37,116	37,450	39,605	-
Capital Lease Obligations	-	-	-	-	-
Deferred Income Tax	2,166	2,881	3,034	3,809	4,501
Minority Interest	57	63	61	65	60
Other Liabilities, Total	6,063	6,331	6,263	7,019	7,090
Total Equity	31,118	32,734	32,661	31,645	35,946
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	0	0	-	-	-
Common Stock, Total	292	292	292	292	-
Additional Paid-In Capital	45,165	44,956	44,375	43,756	44,361
Retained Earnings (Accumulated Deficit)	24,675	24,217	23,948	23,820	-
Treasury Stock - Common	-38,618	-36,411	-35,292	-35,187	-31,259
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	1	2	-	-	-
Other Equity, Total	-1,224	-778	-931	-1,164	-1,208
Total Liabilities & Shareholders' Equity	96,820	98,196	100,357	103,034	109,314
Total Common Shares Outstanding	2,098	2,124	2,135	2,129.06	2,153
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.